All In Biotech

Free tool

FAERS Monitor: Norditropin Flexpro

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 021148 or its brand name (Norditropin Flexpro, Somatropin). Reports on generic versions are filed under their own applications.

Reports

9,514

Serious

6,529

69% of reports

Hospitalization

2,552

Death reported

504

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use555
  • headache406
  • device leakage347
  • injection site pain302
  • fatigue262
  • drug dose omission by device233
  • drug ineffective233
  • death204
  • pyrexia202
  • product dose omission issue187
  • vomiting185
  • nausea184
  • arthralgia178
  • condition aggravated162
  • seizure161

Reports by year received

View as table
YearReports
200467
200535
200644
2007149
200899
2009276
2010216
2011253
2012297
2013145
2014257
2015371
2016551
2017477
2018553
2019726
2020658
2021545
2022743
2023991
2024879
2025672
2026510

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,645 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
device leakageSignal34717.816.15,462
drug dose omission by deviceSignal2336.65.81,101
seizureSignal1613.12.6226
injection site painSignal3022.21.9194
headache4061.41.354
product dose omission issue1871.41.222
off label use5551.41.366
pyrexia2021.31.113
condition aggravated1621.21.04
arthralgia1780.90.80
vomiting1850.90.84
fatigue2620.70.724
death2040.50.592
nausea1840.50.487
drug ineffective2330.40.3235

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.